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Abstract The aim of this study was to analyze the preva-
lence and prognostic importance of paratracheal lymph
nodes in squamous cell carcinoma of the hypopharynx.
A retrospective review of 64 previously untreated patients
with squamous cell carcinoma (SCC) of the hypopharynx
that underwent surgery was performed. Ipsilateral paratrac-
heal lymph node metastases occurred in 22% (14 out of 64)
and the mean number of paratracheal lymph nodes dis-
sected per side was 2.3 (range 1–6). Contralateral paratrac-
heal lymph node metastases were present in 2% (1 out of
42). Sixty-seven percent with postcricoid SCC and 22%
with pyriform sinus SCC developed clinical node-positive
ipsilateral paratracheal lymph node metastases, whereas
11% with posterior pharyngeal wall SCC developed para-
tracheal metastases. There was a signiWcant correlation
between paratracheal lymph node metastasis and cervical
metastasis (p = 0.005), and the primary tumor site (postcri-
coid, 57.1%; pyriform sinus, 20.0%; posterior pharyngeal
wall, 8.3%) (p = 0.039). Patients with no evidence of para-
tracheal lymph node metastasis may have a survival beneWt
(5-year disease-speciWc survival rate, 60 vs. 29%). How-
ever, this result did not reach statistical signiWcance
(p = 0.071). The patients with SCC of the postcricoid and/
or pyriform sinus were at risk for ipsilateral paratracheal
lymph node metastasis; furthermore, patients with paratrac-
heal node metastasis had a high frequency of cervical
metastasis and a poorer prognosis. Therefore, routine ipsi-
lateral paratracheal node dissection is recommended during
the surgical treatment of patients with SCC of the postcri-
coid and/or pyriform sinus with clinical node metastases.
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Introduction
The hypopharynx is subdivided anatomically into three
areas: the pyriform sinus, the posterior pharyngeal wall,
and the postcricoid region. Among these sites, carcinomas
develop most frequently in the pyriform sinus region. Hyp-
opharyngeal squamous cell carcinoma (SCC) is a very
aggressive cancer that is generally diagnosed at advanced
stages and consequently has a poor prognosis and low sur-
vival. More than 75% of patients with hypopharyngeal
tumors have stage III or IV disease at presentation [1]. Cer-
vical metastases are present in 60–80% of patients and sig-
nify more advanced disease and a poorer prognosis [2, 3].
For this reason, treatment modalities for SCCs at these sites
must address the potential for spread of disease to the neck,
even for early primary tumors. In this regard, both surgery
and radiotherapy are the mainstays of most curative eVorts
aimed at this disease.
Metastases to the thyroid gland and paratracheal lymph
nodes occur in 30% of patients with hypopharyngeal
tumors [4]. A 20% frequency of occult nodal metastases to
ipsilateral paratracheal lymph nodes has been reported in
patients with postcricoid lesions and tumors that involve
the pyriform fossa apex that are stage N0 [5]. For laryngeal/
hypopharngeal and upper esophageal tumors metastatic
disease involving the paratracheal nodal group has been
implicated in recurrent disease, particularly in patients with
peristomal recurrence; this suggests the prognostic
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signiWcance of positive paratracheal metastatic spread
[6, 7]. Treatment planning for patients with paratracheal
metastasis must take into consideration the likelihood of
regional recurrence and/or distant metastasis.
The purpose of this study was to analyze the paratracheal
nodal yield and frequency of metastases, and determine
their relationship with cervical nodal metastases, and over-
all survival in patients with hypopharyngeal SCC.
Materials and methods
Patients
The study group consisted of 64 patients that were not pre-
viously treated for SCC of the hypopharynx; they under-
went surgery at the Department of Otolaryngology-Head
and Neck Surgery, College of Medicine, The Catholic
University of Korea, Seoul, Korea, from October 1993 to
June 2008. The cases were reviewed retrospectively. The
diagnostic evaluations at presentation included a complete
physical examination, panendoscopy, CT and/or MRI scans
of the head and neck, chest X-rays, and laboratory tests. We
assessed the CT and/or MRI to determine the regional
lymph node status. The panendoscopy was mainly per-
formed under general anesthesia, and it consisted of a
microlaryngoscopy, bronchoscopy, and esophagoscopy.
The pharynx and upper esophagus were examined with a
rigid hypopharyngoscope. No patient had radiological evi-
dence of distant metastases at presentation, and all patients
were treated with curative intent. At our institution, in prin-
cipal, the choice of radical therapy is surgery, including
partial pharyngectomy, and neck lymph node metastasis is
treated by neck dissection. Additional radio(chemo)therapy
is conducted in patient with multiple lymph nodes metasta-
sis. For histopathologic examination, the formalin-Wxed
surgical specimen was vertically or horizontally sectioned
depending on the extent of tumor involvement. The tissue
sections underwent standard histopathologic evaluation and
complete histopathologic review was done in all cases by a
single pathologist. The median age was 61.0 (range 34–
75 years); there were 62 males and 2 females. The survival
outcomes of surgery group of patients were compared with
the outcomes of patients with hypopharyngeal cancer who
were treated at our institution with deWnitive chemoradio-
therapy. From October 1993 to June 2008, 38 patients were
identiWed with SCC of the hypopharynx and had been
treated with concurrent chemoradiotherapy. Of this group
16 patients were treated with curative intent. The patients
were staged according to the 2002 American Joint Commit-
tee on Cancer (AJCC) staging system. The follow-up
period ranged from 7 to 128 months, with a mean of
36.1 months. The Institutional Review Board of the
Kangnam St Mary’s Hospital (Seoul, Korea) approved this
retrospective review of the medical records and the use of
archived tumor specimens.
Surgical procedures
For tumor excision, 40 (63%) patients had conservative sur-
gery with laryngeal preservation, 15 (23%) had total laryn-
gectomy with partial pharyngectomy, 7 (11%) had total
laryngopharyngectomy, and 2 (3%) had a total laryn-
gopharyngoesophagectomy. En bloc resection was per-
formed according to the surgical procedures. Laryngeal
resection was performed under direct vision based on the
invasion of the tumor. The resection of the posterior pha-
ryngeal wall was determined by a safe tumor margin of up
to two-thirds of the lateral dimension of the pharyngeal
wall. The inferior margin could be 2 cm below the upper
margin of the cervical esophagus without causing any post-
operative functional problems. The surgical defects were
reconstructed with a radial forearm free Xap in 36 cases,
pectoralis major myocutaneous Xap in 7 cases, anterolateral
thigh free Xap in 4 cases, and a gastric pull-up in 2 cases.
All patients had neck dissection at the time of the primary
surgery: a radical neck dissection was performed in 27
cases, a modiWed radical neck dissection in 20 cases, and a
selective (level II–IV) neck dissection in 17 cases. For the
56 contralateral cases, selective (level II–IV) neck dissec-
tion was performed in 48 patients and a modiWed radical
neck dissection in 8. Among the 64 patients that had sur-
gery, all patients had an ipsilateral paratracheal lymph node
dissection and 42 patients had bilateral paratracheal node
dissections when there was clinical or radiological evidence
of disease involvement of the cervical lymph nodes bilater-
ally. The paratracheal node dissection included dissection
of all of the nodes between the carotid artery laterally and
the trachea medially, as far inferior into the superior
mediastinum as possible, through the cervical approach.
There was no perioperative mortality. One patient required
re-exploration for vascular compromise of the radial fore-
arm free Xap. Two patients developed marginal necrosis of
the Xap, which resulted in pharyngocutaneous Wstulas that
were managed by healing with secondary intention after
debriding the necrotic tissue in the Xap. There were no
enteric strictures related to the Wstulas. Recurrent laryngeal
nerve injury occurred in two patients of the conservative sur-
gery with laryngeal preservation. One patient could be dec-
annulated, whereas the other patients required the retainer.
Postoperative radiotherapy
Indications and modalities for adjuvant treatments varied
over time: positive or close margins found on the resection,
advanced T stage, lymphovascular invasion, perineuralEur Arch Otorhinolaryngol (2010) 267:945–950 947
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invasion, multiple nodal metastasis, or extracapsular spread
were Wndings that required additional treatment. Fifty-two
(81%) patients had adjuvant radiotherapy, and 12 (19%)
patients received surgery alone. The radiation techniques
used were based on the site of disease and potential areas of
spread. Postoperatively, the patients received a total dose of
55–66 Gy to the site of the lesions with a 1.5–2.0 cm mar-
gin. Treatment was delivered in 2 Gy fractions, with 5 frac-
tions per week.
Statistical analysis
To determine the signiWcance between paratracheal lymph
node metastasis and clinical factors (such as age, gender,
primary tumor site, TN stage, tumor cell diVerentiation,
pyriform sinus apex involvement), the chi-square test,
Fisher’s exact test, multiple logistic regression analysis,
multiple linear regression analysis, and correlation analysis
were used, as appropriate. The overall survival was deter-
mined using the Kaplan–Meier method. The Cox propor-
tional hazard model with likelihood ratio statistics was used
to further evaluate each variable by multivariate survival
analysis. A p < 0.05 was considered statistically signiWcant.
All calculations were performed using SPSS software ver.
13.0 (SPSS, Chicago, IL, USA).
Results
Patient characteristics
The site of the original primary tumor was recorded in all
patients and included: the pyriform sinus in 45 (70%), the
posterior pharyngeal wall in 12 (19%), and the postcricoid
area in 7 (11%). Regarding their pathological stages, there
were 2 (3%), 25 (39%), 25 (39%), and 12 (19%) patients
with stage T1–T4 cancers, respectively. Concerning the
disease stage of the cervical lymph nodes, there were 15
(23%), 10 (16%), 37 (58%), and 2 (3%) cases with N0–N3,
respectively (Table 1). There were 9 (14%) patients with
pyriform sinus apex involvement and 9 (14%) with positive
resection margins. Regarding tumor cell diVerentiation, there
were 9 (14%), 43 (67%), and 12 (19%) well-diVerentiated,
moderate-diVerentiated, and poorly diVerentiated cases,
respectively.
Prevalence of paratracheal nodal metastases
The rate of ipsilateral paratracheal lymph node metastasis
was 22% (14 out of 64) among all cases; 57% (4 out of 7)
had postcricoid carcinoma, 20% (9 out of 45) had pyriform
sinus carcinoma, and 8% (1 of 11) had posterior pharyngeal
wall carcinoma. Contralateral paratracheal lymph node
metastases were present in 1 out of the 42 cases (2%). The
mean number of paratracheal lymph nodes dissected per
side was 2.3 (range 1–6). The CT and/or MRI detected met-
astatic cervical disease accurately in 42 out of the 56 sides
of the neck (75%), whereas they detected metastatic para-
tracheal lymph node accurately in 8 of the 15 cases (53%).
Histological paratracheal metastases in the clinically node-
positive neck were more frequent in patients with postcri-
coid (67%) or pyriform sinus hypopharyngeal SCC (22%)
than in patients with posterior pharyngeal wall SCC (11%)
(Table 2). Patients with SCC of the pyriform sinus had met-
astatic disease more often; histological metastases were
conWrmed in 15% of cases with contralateral dissections, in
the clinically node-positive neck, and in 4% of ipsilateral
dissections, in the clinically node-negative neck.
Relationship between paratracheal lymph node metastasis 
and clinical factors (Table 3.)
We analyzed the correlation between paratracheal lymph
node metastasis and several clinical factors among the 64
patients with hypopharyngeal SCC. There was a signiWcant
correlation of paratracheal lymph node metastasis with the
primary tumor site and N stage (p = 0.039 and p = 0.005,
respectively). However, there was no signiWcant relation-
ship between age (p = 0.253), gender (p =0 . 4 4 7 ) ,  T  s t a g e
(p = 0.862), tumor cell diVerentiation (p = 0.460), pyriform
sinus apex involvement (p = 0.370) and paratracheal lymph
node metastasis. The multivariate analysis showed that the
Table 1 Pathology staging for patients undergoing paratracheal node
dissection (N =6 4 )
Stage N0 N1 N2a N2b N2c N3 Total
T1 1 1 – – – – 2
T 2 55 1 1 0 312 5
T3 6 2 2 8 6 1 25
T4 3 2 1 2 4 – 12
Total 15 10 4 20 13 2 64
Table 2 Incidence of paratracheal nodal metastasis by site of primary
tumor in patients with hypopharyngeal cancer
cN+ Clinically positive lymph node, cN0 clinically negative lymph
node
Level PS PPW PC Total
Ipsilateral (n =6 4 )
cN+ (n = 47) 7/32 1/9 4/6 12/47
cN0 (n = 17) 2/13 0/3 0/1 2/17
Contralateral (n = 42)
cN+ (n = 37) 1/28 0/6 0/3 1/37
cN0 (n = 5) 0/4 0/1 0/0 0/5948 Eur Arch Otorhinolaryngol (2010) 267:945–950
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N stage was signiWcantly correlated with paratracheal
lymph node metastasis (p = 0.009); however, there was no
relationship between paratracheal lymph node metastasis
and age, gender, primary tumor site, T stage, tumor cell
diVerentiation, and pyriform sinus apex involvement.
Relationship between paratracheal lymph node metastasis 
and survival rate
In the 59 patients followed for more than 12 months, there
was a 3-year overall and disease-speciWc survival of 53 and
56%. The 5-year overall and disease-speciWc survival rates
were 49 and 52%, respectively. In the concurrent chemora-
diotherapy group, the 5-year overall survival and disease-
speciWc survival rate were 46 and 49%, respectively.
However, there was no disease-speciWc survival diVerence
between surgery group and chemoradiotherapy group
(p = 0.601). The 5-year disease-speciWc survival among 14
patients with paratracheal lymph node metastasis was 29%,
whereas for the 45 metastasis-free patients it was 60%
(Fig. 1). However, this result did not reach statistical sig-
niWcance (p = 0.071). Cervical nodal metastasis (p = 0.042)
and pyriform sinus apex involvement (p = 0.035) were sta-
tistically signiWcant prognostic factors associated with dis-
ease-speciWc survival. Gender, age, primary tumor site, T
stage, tumor cell diVerentiation, resected margin involve-
ment, and postoperative radiotherapy were not associated
with disease-speciWc survival. The multivariate survival
analysis showed that there was no adverse factor aVecting
disease-speciWc survival.
Discussion
Hypopharyngeal carcinoma has a high tendency to invade
cervical lymph nodes. This nodal extension is a well-
known prognostic factor [8, 9]. The hypopharynx has an
extensive lymphatic network. The lymphatic drainage of
the hypopharynx is divided into anterior and posterior
groups [10]. The anterior collecting system exits, along
with the lymphatics of the supraglottic larynx, through the
thyrohyoid membrane. These vessels course through pre-
laryngeal lymph nodes and primarily drain into Groups II
and III. The posterior group drains the inferior hypophar-
ynx. These vessels penetrate the superior constrictor
muscle and drain into the paratracheal lymph nodes, lateral
retropharyngeal lymph nodes and the internal jugular
chain [7].
Welsh et al. [11] initially conWrmed the importance of
the paratracheal nodes in lymphatic drainage of the larynx
and hypopharynx. Harrison et al. reported that carcinomas
of the subglottic region, trachea, and cervical esophagus are
at a high risk for paratracheal and tracheobronchial lymph
node metastasis, and recommended resection of the manu-
brium to remove these lymph nodes and reduce the risk for
parastomal disease recurrence [5]. Weber et al. [7] reported
on paratracheal lymph node metastasis in patients with
tumors of the larynx (metastasis in 17.6%), pharynx
(metastasis in 8.3%), and esophagus (metastasis in 71.4%).
Some investigators have suggested that ipsilateral paratrac-
heal node dissection should be included as part of a selec-
tive neck dissection in all patients with tumors invading the
subglottis, pyriform fossa apex, and postcricoid region [12].
In our study, the patients with postcricoid SCC had a sig-
niWcantly higher rate of paratracheal lymph node metastasis
compared to patients with pyriform sinus SCC. In addition,
patients with posterior pharyngeal wall SCC had the lowest
rate of paratracheal lymph node metastasis. Furthermore,
paratracheal lymph node metastasis had a signiWcantly
Table 3 Clinical factors aVecting paratracheal lymph node metastasis
in patients with hypopharyngeal squamous cell carcinoma (N =6 4 )
PTN paratracheal lymph node, PS pyriform sinus, PPW posterior pha-
ryngeal wall, PC postcricoid
Parameters PTN positive 
(N = 14)
PTN negative
(N =5 0 )
p value
Age 0.362
<60 6 (16.7%) 30 (83.3%)
¸60 8 (28.6%) 20 (71.4%)
Gender 1.000
Male 14 (22.6%) 48 (77.4%)
Female 0 (0%) 2 (100%)
Primary site 0.039*
PS 9 (20.0%) 36 (80.0%)
PPW 1 (8.3%) 11 (91.7%)
PC 4 (57.1%) 3 (42.9%)
T stage 0.862
T1 0 (0%) 2 (100%)
T2 6 (24.0%) 19 (76.0%)
T3 5 (20.0%) 20 (80.0%)
T4 3 (25.0%) 9 (75.0%)
N stage 0.005*
N0 0 (0%) 15 (100%)
N1 1 (10.0%) 9 (90.0%)
N2 12 (32.4%) 25 (67.6%)
N3 1 (50.0%) 1 (50.0%)
Histologic grade 0.460
Well diVerentiated 1 (11.1%) 8 (88.9%)
Moderately 
diVerentiated
9 (20.9%) 34 (79.1%)
Poorly diVerentiated 4 (33.3%) 8 (66.7%)
Apex involvement 0.397
Yes 3 (33.3%) 6 (66.7%)
No 11 (20.0%) 44 (80.0%)Eur Arch Otorhinolaryngol (2010) 267:945–950 949
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greater risk of cervical lymph node metastases (p = 0.005).
However, we found no signiWcant correlation between
paratracheal lymph node metastasis and age, gender,
T stage, tumor cell diVerentiation, or pyriform sinus apex
involvement.
Advanced-stage neck disease is signiWcantly associated
with increased locoregional recurrence rates and poorer
5-year disease-speciWc survival rates. N2 or N3 neck dis-
ease is associated with 5-year disease-speciWc survival
rates of 0–20% compared to the 28–57% in patients with
N0 or N1 disease [2, 13]. In a prospective study of 50
patients with carcinoma of the larynx, hypopharynx, and
cervical esophagus, Timon et al. [14] reported that the
rate of paratracheal nodal metastases was 26%. Moreover,
they reported that the survival in patients with positive
paratracheal nodes demonstrated a trend towards poorer
survival compared to patients without paratracheal nodal
involvement, and concomitant involvement of both cervi-
cal and paratracheal nodal groups was associated with the
poorest survival probability. Previous reports on surgery
plus postoperative radiation therapy have shown local
recurrence rates of 4–18%, regional recurrence rates
of 17–47% and 5-year disease-speciWc survival rates of
40–59% [2, 13, 15]. Koo et al. [16] reported that the rate
of distant metastasis (26%) was signiWcantly higher than
the rate of locoregional recurrence (9%) in patients with
pyriform sinus carcinoma, and recommended that hypo-
pharyngeal carcinoma should be considered a systemic
disease.
The results of this study showed that the patients with
paratracheal lymph node metastasis had poorer survival
than metastasis-free patients with regard to the 5-year dis-
ease-speciWc survival rates. The rate of the 5-year disease-
speciWc survival decreased dramatically with the presence
of cervical lymph node metastasis and pyriform sinus apex
involvement (p = 0.042 and 0.035, respectively) on the
univariate analysis, but did not reach signiWcance on the
multivariate analysis.
There were some limitations in this study. The main lim-
itation was the retrospective analysis. Second limitation
was the small number of patients with paratracheal node
metastasis of hypopharyngeal carcinoma. Third, patients
with hypopharyngeal carcinoma at diVerent subsites were
not equally distributed. Lastly, the median follow-up time
of this study was rather short. It was thought that there were
limitations of the overall and disease-speciWc survival data.
Further studies with a large number of subjects should be
made to conWrm our Wnding that ipsilateral paratracheal
lymph node metastasis inXuences prognosis and to verify
the conXicting results between our Wndings and those of
previous studies.
Conclusion
The  Wndings of this study of 64 patients with previously
untreated hypopharyngeal carcinoma that had primary sur-
gery and paratracheal lymph node dissection followed by
radiation therapy at a single institution showed a high rate of
ipsilateral paratracheal lymph node metastasis in patients
with SCC of the postcricoid and/or pyriform sinus with clini-
cally node-positive neck Wndings; these patients had a poor
prognosis. Therefore, these Wndings suggest the importance
of routine ipsilateral paratracheal node dissection with surgi-
cal treatment of patients with SCC of the postcricoid and/or
pyriform sinus and clinically positive neck nodes.
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Fig. 1 Kaplan–Meier disease-
speciWc survival curve (a) and 
disease-speciWc survival curve 
according to the paratracheal 
node status (b)
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